Cited by 160Cannabis and Cannabinoid ResearchGlioma Diagnosis and TreatmentCancer, Stress, Anesthesia, and Immune Response

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect

Open access

Solinas, Marta, Massi, Paola, Cinquina, Valentina, Valenti, Marta, Bolognini, Daniele, Gariboldi, Marzia, Monti, Elena, Rubino, Tiziana, Parolaro, Daniela·2013·PLoS ONE

DOI 10.1371/journal.pone.0076918PMC PMC3804588

Open this paper in CoChat — free account Open PDF

Abstract

In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and invasiveness in vitro and caused a decrease in the expression of a set of proteins specifically involved in growth, invasion and angiogenesis. In addition, CBD treatment caused a dose-related down-regulation of ERK and Akt prosurvival signaling pathways in U87-MG and T98G cells and decreased hypoxia inducible factor HIF-1α expression in U87-MG cells. Taken together, these results provide new insights into the antitumor action of CBD, showing that this cannabinoid affects multiple tumoral features and molecular pathways. As CBD is a non-psychoactive phytocannabinoid that appears to be devoid of side effects, our results support its exploitation as an effective anti-cancer drug in the management of gliomas.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0076918

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“HIF-1a is one of the major factors responsible for orchestrating the adaptive transcriptional programs, inducing cell survival, motility and tumor angiogenesis under hypoxic conditions [6,43].”
Background
TGFβ in Cancer
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
Kölch, W. (2000) · Biochemical Journal · doi:10.1042/bj3510289 · Cited by 1,443
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Ten years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177
MAP kinases and cell migration
Huang, C., Jacobson, K., & Schaller, M. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.01481 · Cited by 1,089
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. A., & Fuller, G. N. (2000) · Nature Genetics · doi:10.1038/75596 · Cited by 906
Molecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847

Flagged first, then by citations

Show all 47 references

Sorted by citations

Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 664
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S., & Corsi, L. (2018) · BioMed Research International · doi:10.1155/2018/1691428 · Cited by 430
Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age
Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 268
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
Seltzer, E. S., Watters, A. K., MacKenzie, D., Granat, L. M., & Zhang, D. (2020) · Cancers · doi:10.3390/cancers12113203 · Cited by 260
Cannabinoids in cancer treatment: Therapeutic potential and legislation
Dariš, B., Verboten, M. T., Knez, Ž., & Ferk, P. (2018) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2018.3532 · Cited by 226
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …
Baron, E. P. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 219
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Sun, D., Li, X., Nie, S., Liu, J., & Wang, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113993 · Cited by 195
Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis
Hao, E., Mukhopadhyay, P., Cao, Z., Erdélyi, K., Holovac, E., Liaudet, L., Lee, W.-S., Haskó, G., Mechoulam, R., & Pacher, P. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00261 · Cited by 175
Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders
Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
Scott, K. A., Dalgleish, A. G., & Liu, W. M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0402 · Cited by 155
The Endocannabinoid System: A Target for Cancer Treatment
Laezza, C., Pagano, C., Navarra, G., Pastorino, O., Proto, M., Fiore, D., Piscopo, C., Gazzerro, P., & Bifulco, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030747 · Cited by 149
Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer
Kis, B., Ifrim, F. C., Buda, V. O., Avram, Ș., Pavel, I. Z., Antal, D., Păunescu, V., Dehelean, C. A., Ardelean, F., Diaconeasa, Z. M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235905 · Cited by 148
A Comprehensive Review on Cannabis sativa Ethnobotany, Phytochemistry, Molecular Docking and Biological Activities
Hourfane, S., Mechqoq, H., Bekkali, A. Y., Rocha, J. M., & Aouad, N. E. (2023) · Plants · doi:10.3390/plants12061245 · Cited by 133
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
López-Valero, I., Sáiz-Ladera, C., Torres, S., Hernández‐Tiedra, S., García-Taboada, E., Rodríguez-Fornés, F., Barba‐Aliaga, M., Dávila, D., Salvador, N., Guzmán, M., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.007 · Cited by 114
Cannabinoids in the landscape of cancer
Mangal, N., Erridge, S., Habib, N., Sadanandam, A., Reebye, V., & Sodergren, M. H. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03710-7 · Cited by 119
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
Dumitru, C. A., Sandalcioglu, I. E., & Karsak, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00159 · Cited by 101
The heterogeneity and complexity of Cannabis extracts as antitumor agents
Baram, L., Peled, E., Berman, P., Yellin, B., Besser, E., Benami, M., Louria‐Hayon, I., Lewitus, G. M., & Meiri, D. (2019) · Oncotarget · doi:10.18632/oncotarget.26983 · Cited by 100
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders
Golub, V. M., & Reddy, D. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_7 · Cited by 106
Cannabidiol (CBD) in Cancer Management
O’Brien, K. (2022) · Cancers · doi:10.3390/cancers14040885 · Cited by 90
Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells
Pucci, C., Marino, A., Şen, Ö., Pasquale, D. D., Bartolucci, M., Iturrioz-Rodríguez, N., di Leo, N., de Vito, G., Debellis, D., Petretto, A., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.005 · Cited by 94
Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use
Blebea, N. M., Pricopie, A. I., Vlad, R.-A., & Hancu, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084204 · Cited by 92
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation
Hudson, R., Renard, J., Norris, C., Rushlow, W. J., & Laviolette, S. R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0708-19.2019 · Cited by 97
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
Javid, F. A., Phillips, R. M., Afshinjavid, S., Verde, R., & Ligresti, A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.02.010 · Cited by 82
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Reddy, D. S. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114237 · Cited by 102
Use of Cannabis and Cannabinoids for Treatment of Cancer
Cherkasova, V., Wang, B., Gerasymchuk, M., Fiselier, A., Kovalchuk, O., & Kovalchuk, I. (2022) · Cancers · doi:10.3390/cancers14205142 · Cited by 70
Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
Ożarowski, M., Karpiński, T. M. M., Zielińska, A., Souto, E. B., & Wielgus, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094294 · Cited by 71
Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture
Deng, L., Ng, L., Ozawa, T., & Stella, N. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.236968 · Cited by 67
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
Navarrete, C. M., Carrillo-Salinas, F. J., Palomares, B., Mecha, M., Jiménez‐Jiménez, C., Mestre, L., Feliú, A., Bellido, M. L., Fiebich, B. L., Appendino, G., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1103-y · Cited by 63
The use of cannabis in supportive care and treatment of brain tumor
Likar, R., & Nahler, G. (2017) · Neuro-Oncology Practice · doi:10.1093/nop/npw027 · Cited by 61
A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas
Schloss, J. M., Lacey, J., Sinclair, J., Steel, A., Sughrue, M. E., Sibbritt, D. W., & Teo, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.649555 · Cited by 61
Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in Human and Canine Glioma Cells
Gross, C. C., Ramirez, D. A., McGrath, S., & Gustafson, D. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.725136 · Cited by 58
Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells
Kosgodage, U. S., Onganer, P. U., MacLatchy, A., Mould, R. R., Nunn, A. V. W., Guy, G. W., Kraev, I., Chatterton, N. P., Thomas, E. L., Inal, J. M., et al. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.12.004 · Cited by 58
Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays
Aleshin, V. A., Artiukhov, A. V., Oppermann, H., Kazantsev, A. V., Lukashev, N. V., & Bunik, V. I. (2015) · Cells · doi:10.3390/cells4030427 · Cited by 58
Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-radiation and small molecule inhibitors of cell signaling pathways
Ivanov, V. N., Wu, J., & Hei, T. K. (2017) · Oncotarget · doi:10.18632/oncotarget.18240 · Cited by 61
In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy
Martín‐Banderas, L., Muñoz-Rubio, I., Prados, J. C., Álvarez‐Fuentes, J., Calderón‐Montaño, J. M., López‐Lázaro, M., Arias, J. L., Leiva, M. C., Holgado, M. A., & Arévalo, M. F. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.054 · Cited by 56
The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory
Khan, M. I., ska, A. A. S., Czarnecka, A. M., Król, M., Botta, B., & Szczylik, C. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151211094901 · Cited by 57
Inflammation and cancer: friend or foe?
Smith, A. D. T., Córdoba-Hernandez, S., Mejía-Guarnizo, L. V., Monroy-Camacho, P. S., & Rodríguez-García, J. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1385479 · Cited by 53
Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
Cheng, B., Morales, L. D., Zhang, Y., Mito, S., & Tsin, A. T. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184324 · Cited by 51
Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective
Mashabela, M. D., & Kappo, A. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115659 · Cited by 47
The Current and Potential Application of Medicinal Cannabis Products in Dentistry
Lowe, H. I. C., Toyang, N. J., Steele, B., Bryant, J., Ngwa, W. F., & Nedamat, K. (2021) · Dentistry Journal · doi:10.3390/dj9090106 · Cited by 51
Delta9‐tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature
Fowler, C. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.84 · Cited by 44
Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol
Dall'Stella, P. B., Docema, M. F. L., Maldaun, M. V. C., Feher, O., & Lancellotti, C. L. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00643 · Cited by 42
Non‐psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors‐, endocannabinoids‐, and NF‐κB ‐mediated signaling
Borgonetti, V., Benatti, C., Governa, P., Isoldi, G., Pellati, F., Alboni, S., Tascedda, F., Montopoli, M., Galeotti, N., Manetti, F., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7458 · Cited by 42
Biological effects of cannabidiol on human cancer cells: Systematic review of the literature
Valenti, C., Billi, M., Pancrazi, G. L., Calabria, E., Armogida, N. G., Tortora, G., Pagano, S., Barnaba, P., & Marinucci, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106267 · Cited by 42
Current natural therapies in the treatment against glioblastoma
Erices, J. I., Torres, Á., Niechi, I., Bernales, I., & Quezada, C. (2018) · Phytotherapy Research · doi:10.1002/ptr.6170 · Cited by 41
Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment
Khodadadi, H., Salles, É. L., Alptekin, A., Mehrabian, D., Rutkowski, M. J., Arbab, A. S., Yeudall, W. A., Yu, J. C.-K., Morgan, J. C., Hess, D. C., et al. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0098 · Cited by 38
Anti-proliferative and cytotoxic effect of cannabidiol on human cancer cell lines in presence of serum
Sainz-Cort, A., Müller‐Sánchez, C., & Espel, E. (2020) · BMC Research Notes · doi:10.1186/s13104-020-05229-5 · Cited by 39
Cannabidiol Suppresses Angiogenesis and Stemness of Breast Cancer Cells by Downregulation of Hypoxia-Inducible Factors-1α
Jo, M. J., Kim, B. G., Kim, W. Y., Lee, D.-H., Yun, H. K., Jeong, S., Park, S. H., Kim, B. R., Kim, J. L., Kim, D. Y., et al. (2021) · Cancers · doi:10.3390/cancers13225667 · Cited by 39
Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro
Peeri, H., Shalev, N., Vinayaka, A. C., Nizar, R., Kazimirsky, G., Namdar, D., Anil, S. M., Belausov, E., Brodie, C., & Koltai, H. (2021) · Cancers · doi:10.3390/cancers13071720 · Cited by 36
Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases
Bukowska, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312738 · Cited by 42
The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib
Maggi, F., Morelli, M. B., Tomassoni, D., Marinelli, O., Aguzzi, C., Zeppa, L., Nabissi, M., Santoni, G., & Amantini, C. (2021) · Cancer Science · doi:10.1111/cas.15257 · Cited by 34
THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner
Kolbe, M. R., Hohmann, T., Hohmann, U., Ghadban, C., Mackie, K., Zöller, C., Prell, J., Illert, J., Strauß, C., & Dehghani, F. (2021) · Cancers · doi:10.3390/cancers13051064 · Cited by 34
Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities
Peeri, H., & Koltai, H. (2022) · Biomolecules · doi:10.3390/biom12040491 · Cited by 32
Cannabinoids as anticancer and neuroprotective drugs: Structural insights and pharmacological interactions—A review
Pugazhendhi, A., Suganthy, N., Chau, T. P., Sharma, A. K., Unpaprom, Y., Ramaraj, R., Karuppusamy, I., & Brindhadevi, K. (2021) · Process Biochemistry · doi:10.1016/j.procbio.2021.08.025 · Cited by 32
Bioactive Heterocyclic Compounds as Potential Therapeutics in the Treatment of Gliomas: A Review
Hassan, R., Mohi-ud-din, R., Dar, M. O., Shah, A. J., Mir, P. A., Shaikh, M., & Pottoo, F. H. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210901112954 · Cited by 31
Cannabinoid Signaling in Glioma Cells
Ellert‐Miklaszewska, A., Ciechomska, I. A., & Kaminska, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-30651-9_11 · Cited by 30
Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models
Soroceanu, L., Singer, E. A., Dighe, P. A., Sidorov, M., Limbad, C., Rodriguez-Brotons, A., Rix, P. J., Woo, R. W. L., Dickinson, L., Desprez, P., et al. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac019 · Cited by 29
Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
Olivas-Aguirre, M., Torres-López, L., Villatoro-Gómez, K., Pérez‐Tapia, S. M., Pottosin, I. I., & Dobrovinskaya, O. R. (2022) · Pharmaceuticals · doi:10.3390/ph15030366 · Cited by 31
Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1
D’Aloia, A., Ceriani, M., Tisi, R., Stucchi, S., Sacco, E., & Costa, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137145 · Cited by 29
Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches
Iozzo, M., Sgrignani, G., Comito, G., Chiarugi, P., & Giannoni, E. (2021) · Cells · doi:10.3390/cells10123396 · Cited by 29
RETRACTED ARTICLE: Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures
Ivanov, V. N., Grabham, P. W., Wu, C., & Hei, T. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-59468-4 · Cited by 27
Retracted
The effect of cannabidiol on canine neoplastic cell proliferation and mitogen‐activated protein kinase activation during autophagy and apoptosis
Henry, J. G., Shoemaker, G., Prieto, J. M., Hannon, M. B., & Wakshlag, J. J. (2020) · Veterinary and Comparative Oncology · doi:10.1111/vco.12669 · Cited by 34
Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies
Wang, F., & Multhoff, G. (2021) · Biomolecules · doi:10.3390/biom11040582 · Cited by 28
Cannabidiol Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells
O’Reilly, E., Khalifa, K., Cosgrave, J. M., Azam, H., Prencipe, M., Simpson, J. C., Gallagher, W. M., & Perry, A. S. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00363 · Cited by 26
Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex
Serra, I., Scheldeman, C., Bazelot, M., Whalley, B. J., Dallas, M. L., de Witte, P. A. M., & Williams, C. M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.040 · Cited by 25
Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells
Giacomo, S. D., Mariano, A., Gullì, M., Fraschetti, C., Vitalone, A., Filippi, A., Mannina, L., d’Abusco, A. S., & Sotto, A. D. (2021) · Molecules · doi:10.3390/molecules26216688 · Cited by 24
Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
Maia, J., Fonseca, B. M., Teixeira, N. A. A., & Correia‐da‐Silva, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115686 · Cited by 24
Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products
Afshari, A. R., Mollazadeh, H., Soukhtanloo, M., Hosseini, A., Mohtashami, E., Jalili‐Nik, M., Modaresi, S. M. S., Soltani, A., & Sahebkar, A. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200807133659 · Cited by 23
Cannabidiol Decreases Metalloproteinase Activity and Normalizes Angiogenesis Factor Expression in UVB‐Irradiated Keratinocytes from Psoriatic Patients
Gęgotek, A., Atalay, S., Wroński, A., Markowska, A., & Skrzydlewska, E. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7624389 · Cited by 23
Biological Activity of Cannabis sativa L. Extracts Critically Depends on Solvent Polarity and Decarboxylation
Moreno‐Sanz, G., Ferreiro‐Vera, C., Callado, C. S.-C., Nadal, X., & de Medina, V. S. (2020) · Separations · doi:10.3390/separations7040056 · Cited by 23
Cannabidiol (CBD) Oil Does Not Display an Entourage Effect in Reducing Cancer Cell Viability in vitro
Raup‐Konsavage, W. M., Carkaci‐Salli, N., Greenland, K., Gearhart, R., & Vrana, K. E. (2020) · Medical Cannabis and Cannabinoids · doi:10.1159/000510256 · Cited by 22
The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects
Hosami, F., Ghadimkhah, M. H., Salimi, V., Ghorbanhosseini, S. S., & Tavakoli‐Yaraki, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112279 · Cited by 21
Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials
Hasan, N., Imran, M., Sheikh, A., Saad, S., Chaudhary, G., Jain, G. K., Kesharwani, P., & Ahmad, F. J. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2056188 · Cited by 22
Research Progress on the Mechanism of the Antitumor Effects of Cannabidiol
Ma, L., Liu, M., Liu, C., Zhang, H., Yang, S., An, J., Qu, G., Song, S., & Cao, Q. (2024) · Molecules · doi:10.3390/molecules29091943 · Cited by 20
Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives
Lefranc, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.618961 · Cited by 20
Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
Cherkasova, V., Kovalchuk, O., & Kovalchuk, I. (2021) · Cancers · doi:10.3390/cancers13174353 · Cited by 20
Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD)
Fu, J., Zhang, K., Lu, L., Li, M., Han, M., Guo, Y., & Wang, X. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081533 · Cited by 19
Antitumor mechanism of cannabidiol hidden behind cancer hallmarks
Yan, C., Li, Y., Liu, H., Chen, D., & Wu, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188905 · Cited by 19
On the influence of cannabinoids on cell morphology and motility of glioblastoma cells
Hohmann, T., Feese, K., Ghadban, C., Dehghani, F., & Hohmann, U. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212037 · Cited by 18
Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition
Şahin, Z., Biltekin, S. N., Yurttaş, L., Berk, B., Özhan, Y., Si̇pahi̇, H., Gao, Z., Jacobson, K. A., & Demirayak, Ş. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113125 · Cited by 18
Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature
Hanganu, B., Lazăr, D. E., Manoilescu, I. S., Mocanu, V., Butcovan, D., Buhaș, C. L., Szalontay, A. S., & Ioan, B. G. (2022) · Cancers · doi:10.3390/cancers14164057 · Cited by 19
Efficacy of cannabinoids against glioblastoma multiforme: A systematic review
Kyriakou, I., Yarandi, N., & Polycarpou, E. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153533 · Cited by 16
Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles
Kuźmińska, J., Sobczak, A., Majchrzak‐Celińska, A., Żółnowska, I., Gostyńska, A., Jadach, B., Krajka‐Kuźniak, V., Jelińska, A., & Stawny, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082104 · Cited by 16
Mannich-type modifications of (−)-cannabidiol and (−)-cannabigerol leading to new, bioactive derivatives
Lőrincz, E. B., Tóth, G., Spolárics, J., Herczeg, M., Hodek, J., Zupkó, I., Minorics, R., Ádám, D., Oláh, A., Zouboulis, C. C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45565-7 · Cited by 16
The pharmacological basis for application of cannabidiol in cancer chemotherapy
Zhelyazkova, M., Kirilov, B., & Momekov, G. (2020) · Pharmacia · doi:10.3897/pharmacia.67.e51304 · Cited by 16
Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects
Hu, Z., Qin, Z., Xie, J., Qu, Y., & Yin, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116271 · Cited by 15
From bench to bedside: the application of cannabidiol in glioma
Feng, S., Pan, Y., Lu, P., Li, N., Zhu, W., & Hao, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05477-0 · Cited by 16
Cannabis sativa L. Constituents and Their Role in Neuroinflammation
Borgonetti, V., Governa, P., Montopoli, M., & Biagi, M. (2019) · Current Bioactive Compounds · doi:10.2174/1573407214666180703130525 · Cited by 15
The synergistic anticancer effect of CBD and DOX in osteosarcoma
Li, J., Jiang, W., Shan, W., Luo, A., Qu, G., Zhang, J., Luo, X., & Xia, J. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03119-3 · Cited by 14
Synthetic Cannabinoids Influence the Invasion of Glioblastoma Cell Lines in a Cell- and Receptor-Dependent Manner.
Hohmann, T., Feese, K., Greither, T., Ghadban, C., Jäger, V., Dehghani, F., & Hohmann, U. (2019) · Cancers · doi:10.3390/cancers11020161 · Cited by 14
Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations
Vikram, E. N. T., Ilavarasan, R., & Kamaraj, R. (2022) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2022.100545 · Cited by 14
Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol
Macpherson, T., Armstrong, J. A., Criddle, D. N., & Wright, K. L. (2014) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-013-9719-9 · Cited by 14
Herbal Medicine for Glioblastoma: Current and Future Prospects
Khan, I., Mahfooz, S., & Hatiboğlu, M. A. (2020) · Medicinal Chemistry · doi:10.2174/1573406416666200130100833 · Cited by 12
Preparation and characterization of PBS (Polybutylene Succinate) nanoparticles containing cannabidiol (CBD) for anticancer application
Freire, N. F., Cordani, M., Aparicio-Blanco, J., Fraguas‐Sánchez, A. I., Dutra, L. D. S., Pinto, M. C. C., Zarrabi, A., Pinto, J. C., Velasco, G., & Fialho, R. L. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105833 · Cited by 11
Cannabinoid and Opioid Receptor Affinity and Modulation of Cancer-Related Signaling Pathways of Machaeriols and Machaeridiols from Machaerium Pers.
Muhammad, I., Ibrahim, M. A., Kumarihamy, M., Lambert, J. A., Zhang, J., Mohammad, M. H., Khan, S. I., Pasco, D. S., & Balachandran, P. (2023) · Molecules · doi:10.3390/molecules28104162 · Cited by 10
Synthesis of (−)‐Cannabidiol (CBD), (−)‐Δ9‐ and (−)‐Δ8‐Tetrahydrocannabinols, Encapsulation of CBD with Nanoparticles for Controlled Delivery and Biological Evaluation
Moya‐Utrera, F., Fuentes‐Ríos, D., Romero‐Carrasco, A., Doña‐Flores, M., Cheng‐Sánchez, I., Díaz, A., Pino-González, M. S., Martinez-Ferez, A., Moreno, J., Mesas, C., et al. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202402496 · Cited by 11
Extraction of Cannabinoids and Terpenes from Hemp Flowers and Leaves (Cannabis sativa L., Futura 75): Chemical Profiling and Evaluation of Anticancer Properties
Haczkiewicz, M., Świtalska, M., Łyczko, J., Pluta, M., Wietrzyk, J., & Gliszczyńska, A. (2025) · Molecules · doi:10.3390/molecules30061325 · Cited by 10
Cannabinoids as Potential Cancer Therapeutics: The Concentration Conundrum
Carkaci‐Salli, N., Raup‐Konsavage, W. M., Karelia, D. N., Sun, D., Jiang, C., Lü, J., & Vrana, K. E. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0344 · Cited by 10
Sturge–Weber syndrome: Updates in pathogenesis, diagnosis, and treatment
Valery, C. B., & Comi, A. M. (2023) · Annals of the Child Neurology Society · doi:10.1002/cns3.20031 · Cited by 9

Authors: Solinas, M., Massi, P., Cinquina, V., Valenti, M., Bolognini, D., Gariboldi, M., Monti, E., Rubino, T., & Parolaro, D.
Affiliations: University of Insubria (IT)
University of Milan (IT)
University of Toronto (CA)
Corresponding author: Parolaro, Daniela
ORCID: Cinquina, Valentina
Valenti, Marta
Bolognini, Daniele
Gariboldi, Marzia
Monti, Elena
Rubino, Tiziana
Parolaro, Daniela
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2013-10-21
Volume: 8
Issue: 10
Pages: e76918
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0076918
PMC: PMC3804588
OpenAlex: W2083034715
Cited by: 159
References: 47
Citations by year: 2026: 14 · 2025: 8 · 2024: 17 · 2023: 22 · 2022: 21 · 2021: 24 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 6 · 2016: 4 · 2015: 7 · 2014: 3
FWCI: 3.43
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
IrInSubria (University of Insubria) (submittedVersion)
Funders: Università degli Studi di Milano
GW Pharmaceuticals
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
Keywords: cannabidiol, glioma, U87 cells, T98G cells, cell proliferation, tumor invasion, angiogenesis, ERK signaling, Akt signaling, HIF-1α, anticancer activity, phytocannabinoids
MeSH terms: Antineoplastic Agents, Cannabidiol, Cell Movement, Cell Survival, Dose-Response Relationship, Drug, Glioma, Humans, Neoplasm Invasiveness, Blotting, Western, Signal Transduction, Proteome, Proteomics, Cell Line, Tumor, Extracellular Signal-Regulated MAP Kinases, Cell Proliferation, Proto-Oncogene Proteins c-akt, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks